Patients access to precision oncology
6 Jul 2018
Patients access to precision oncology
U.S. National Cancer Institute perspective on precision oncology
MyPathway study: a novel precision oncology multiple basket trial
Implementing precision medicine in oncology: The IMPACT trials
Lessons from long-term survey of stage I NSCLC
Editor's Choice for June 2018
ASCO 2018 conference round up
Treating CLL with obinutuzumab
First in-human trial of AMV564 for AML
SETBP1 induces transcription of developmental genes
Efficacy of novel agents in r/r T pro-lymphocytic leukaemia
Development of a risk stratifying prognostic index for ALL